french  english  

accueil                                                companyscientific advisorsindicationsapproach

Combination Therapy for Brain-Trauma

Our first goal ist the development of a medicinal therapy consisting of a drug combination, to limit the deleterious consequences of trauma to brain and spine (CNS trauma)

Our vision is to use combination therapy fo CNS trauma as leverage for indications where evidence for combination therapy has accumulated & several single drugs with different MoA exist that ALMOST succeeded:

Alzheimer disease – Stroke – Motoneuron Disease

3CE Pharma

For further information on exploring business opportunities with 3CE Pharma please contact: Ralf Bäuerle, CEO

tel +49 (0) 1577 39 55 667 


For general enquiries please write to:

Copyright 2014 3CE Pharma         Combination Therapy for Brain-Trauma         Legal Notices